The use of LCMV-specific T cell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation [1]

Journal of Immunological Methods

Volumn 237, Issue 1-2, 2000, Pages 199-202

  Schwarz, Katrin ^a   Van Den Broek, Maries ^b   De Giuli, Rita ^a   Seelentag, Wolfhart W ^a   Shastri, Nilabh ^c   Groettrup, Marcus ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS GLYCOPROTEIN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CYTOTOXICITY; HUMAN; HUMAN CELL; HYBRIDOMA; LETTER; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

CHORIOMENINGITIS VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;

EID: 0034599679     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00236-7     Document Type: Article

References (4)

1. Gallimore A., Dumrese T., Hengartner H., Zinkernagel R.M., Rammensee H.-G. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J. Exp. Med. 187:1998;1647-1657.
2. Gallimore A., Schwarz K., van den Broek M., Hengartner H., Groettrup M. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope. Mol. Immunol. 35:1998;581-591.
3. Sanderson S., Shastri N. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6:1994;369-376.
4. b complex to T cells. J. Immunol. 150:1993;2724-2736.